The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2026

Filed:

Apr. 29, 2021
Applicant:

Washington University, St. Louis, MO (US);

Inventors:

Katherine Basore, St. Louis, MO (US);

Michael Diamond, St. Louis, MO (US);

Hongming MA, St. Louis, MO (US);

Natasha Kafai, St. Louis, MO (US);

Arthur Kim, St. Louis, MO (US);

Larissa Thackray, St. Louis, MO (US);

Daved Fremont, St. Louis, MO (US);

Assignee:

Washington University, St. Louis, MO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 38/00 (2006.01); C07K 14/005 (2006.01); C07K 14/705 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); C07K 14/005 (2013.01); C07K 14/705 (2013.01); C12N 7/00 (2013.01); A61K 38/00 (2013.01); C07K 2317/76 (2013.01); C07K 2319/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/43 (2013.01); C07K 2319/60 (2013.01); C12N 2770/36122 (2013.01);
Abstract

Compositions and methods for treating a viral infection may comprise use of a viral recognition-site inhibiting agent composition. A viral recognition-site inhibiting agent composition of the present disclosure may substantially inhibit, reduce, or block virus bind to the LDLRAD3 host receptor and reduces the infectivity of a virus for a host cell. A method of treating a viral infection may comprise administering a composition comprising a viral recognition-site inhibiting agent of the present disclosure, to a subject and reducing the infectivity of the virus for a host cell of the subject. The compositions may be administered via intranasal or systemic administration to treat or prevent a viral infection, for example an alphavirus infection.


Find Patent Forward Citations

Quick Actions:

Basore, Katherine. (2026). Compositions and methods for inhibiting viral recognition sites (U.S. Patent No. 12799194). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12799194

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…